{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:52:44Z","timestamp":1791643964544,"version":"4.3.4"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["73506"],"award-info":[{"award-number":["73506"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.TBZMED.AEC.1403.024"],"award-info":[{"award-number":["IR.TBZMED.AEC.1403.024"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119181","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:09:37Z","timestamp":1773778177000},"page":"119181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Targeted cytosolic delivery of mRNA immunotherapeutics: From vaccine delivery to protein replacement"],"prefix":"10.1016","volume":"198","author":[{"given":"Ehsan Mofidi","family":"Chelan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Parhizkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Almassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Ghasemi","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-3516","authenticated-orcid":false,"given":"Amir","family":"Zarebkohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Pourseif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10432","key":"10.1016\/j.biopha.2026.119181_bib1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119181_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2023.111015","article-title":"Potential health risks of mRNA-based vaccine therapy: a hypothesis","volume":"171","author":"Acevedo-Whitehouse","year":"2023","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001812","article-title":"Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Health Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-023-00977-5","article-title":"mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications","volume":"30","author":"Wang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib7","article-title":"Potent Liver-Tropic mRNA Lipid Nanoparticles: ApoE-Mediated Delivery Through a Low-Density Lipoprotein Receptor Independent Uptake Mechanism","author":"Sarode","year":"2025","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biopha.2026.119181_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fmre.2023.02.022","article-title":"mRNA therapeutics: New vaccination and beyond","volume":"3","author":"Wei","year":"2023","journal-title":"Fundam. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010166","article-title":"mRNA in the Context of Protein Replacement Therapy","volume":"15","author":"Vavilis","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-3-reviews0004","article-title":"Untranslated regions of mRNAs","volume":"3","author":"Mignone","year":"2002","journal-title":"Genome Biol."},{"issue":"20","key":"10.1016\/j.biopha.2026.119181_bib12","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1073\/pnas.89.20.9612","article-title":"A fraction of the mRNA 5\u2032 cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus","volume":"89","author":"Lejbkowicz","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032976","article-title":"The Functional Meaning of 5\u2032UTR in Protein-Coding Genes","volume":"24","author":"Ryczek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajhg.2023.12.017","article-title":"Regulatory features aid interpretation of 3\u2032UTR variants","volume":"111","author":"Romo","year":"2024","journal-title":"Am. J. Hum. Genet."},{"issue":"16","key":"10.1016\/j.biopha.2026.119181_bib16","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1093\/nar\/gkw551","article-title":"mRNA capping: biological functions and applications","volume":"44","author":"Ramanathan","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119181_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114961","article-title":"Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics","volume":"199","author":"Kang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib19","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41467-024-49508-2","article-title":"Optimizing 5\u2019UTRs for mRNA-delivered gene editing using deep learning","volume":"15","author":"Castillo-Hair","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib20","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/s41467-021-24436-7","article-title":"High-throughput 5\u2032 UTR engineering for enhanced protein production in non-viral gene therapies","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020888","article-title":"Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis","volume":"25","author":"Reshetnikov","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41467-022-28776-w","article-title":"Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics","volume":"13","author":"Leppek","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf225","article-title":"Multi-objective computational optimization of human 5\u2032 UTR sequences","volume":"26","author":"Yamada","year":"2025","journal-title":"Brief. Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib24","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1038\/s41467-024-51301-0","article-title":"N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation","volume":"15","author":"Monroe","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119181_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2021.11.022","article-title":"Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery","volume":"341","author":"Melamed","year":"2022","journal-title":"J. Control. Release"},{"issue":"7993","key":"10.1016\/j.biopha.2026.119181_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74091-z","article-title":"Codon optimization with deep learning to enhance protein expression","volume":"10","author":"Fu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119181_bib28","first-page":"31","article-title":"Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action","volume":"440","author":"Maruggi","year":"2022","journal-title":"Curr. Top. Microbiol Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41467-023-35844-2","article-title":"TLR3 forms a laterally aligned multimeric complex along double-stranded RNA for efficient signal transduction","volume":"14","author":"Sakaniwa","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2026.119181_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103341","article-title":"Self-amplifying mRNA vaccines: Mode of action, design, development and optimization","volume":"27","author":"Pourseif","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","article-title":"Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers","volume":"16","author":"Maine","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41541-022-00549-y","article-title":"A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability","volume":"7","author":"Voigt","year":"2022","journal-title":"npj Vaccin."},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41587-024-02306-z","article-title":"Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency","volume":"43","author":"McGee","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib35","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1016\/S1473-3099(24)00615-7","article-title":"12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2026.119181_bib36","article-title":"The therapeutic potential of circular RNAs","author":"O\u2019Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.biopha.2026.119181_bib37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.ymthe.2023.01.019","article-title":"A trans-amplifying RNA simplified to essential elements is highly replicative and robustly immunogenic in mice","volume":"31","author":"Perkovic","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119181_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jconrel.2021.12.008","article-title":"The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency","volume":"342","author":"Anderluzzi","year":"2022","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/v15030668","article-title":"Research Advances on the Stability of mRNA Vaccines","volume":"15","author":"Cheng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2026.119181_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100746","article-title":"mRNA vaccines: A matter of delivery","volume":"32","author":"Cao","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ymthe.2024.03.022","article-title":"Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity","volume":"32","author":"Abbasi","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119181_bib42","article-title":"Advances in nanoparticles in targeted drug delivery\u2013A review","volume":"19","author":"Islam","year":"2025","journal-title":"Results Surf. Interfaces"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119181_bib44","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1021\/acs.molpharmaceut.8b01313","article-title":"Enhanced Delivery of Plasmid DNA to Skeletal Muscle Cells using a DLC8-Binding Peptide and ASSLNIA-Modified PAMAM Dendrimer","volume":"16","author":"Jativa","year":"2019","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2026.119181_bib46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/IJN.S38378","article-title":"Nanodrugs: pharmacokinetics and safety","author":"Onoue","year":"2014","journal-title":"Int J. Nanomed. 9"},{"key":"10.1016\/j.biopha.2026.119181_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.055","article-title":"Investigating the stability of RNA-lipid nanoparticles in biological fluids: Unveiling its crucial role for understanding LNP performance","volume":"381","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"issue":"39","key":"10.1016\/j.biopha.2026.119181_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404510","article-title":"Beyond the Endosomal Bottleneck: Understanding the Efficiency of mRNA\/LNP Delivery","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.biopha.2026.119181_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12101148","article-title":"Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib50","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119181_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01511-8","article-title":"Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level","author":"Kang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib52","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2174\/1389450122666210118105122","article-title":"The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery","volume":"22","author":"Bao","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"15","key":"10.1016\/j.biopha.2026.119181_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202688","article-title":"Polymer-Based mRNA Delivery Strategies for Advanced Therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2026.119181_bib54","article-title":"BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery","author":"Yogasundaram","year":"2012","journal-title":"Int J. Biomater. 2012"},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202300006","article-title":"Ionizable Lipid Nanoparticles for mRNA Delivery","volume":"3","author":"Tang","year":"2023","journal-title":"Adv. NanoBiomed Res."},{"issue":"15","key":"10.1016\/j.biopha.2026.119181_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501037","article-title":"Rational design of unsaturated, thioether ionizable lipids for enhanced In Vivo mRNA delivery","volume":"14","author":"Samaridou","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib57","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib58","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-025-59501-y","article-title":"Structure-guided design of endosomolytic chloroquine-like lipid nanoparticles for mRNA delivery and genome editing","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119181_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-025-02044-6","article-title":"Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines","author":"Rudra","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119181_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040459","article-title":"Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs","author":"Heredero","year":"2025","journal-title":"Pharmaceutics"},{"issue":"33","key":"10.1016\/j.biopha.2026.119181_bib61","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1039\/D4TB00960F","article-title":"Enhancing spleen-targeted mRNA delivery with branched biodegradable tails in lipid nanoparticles","volume":"12","author":"Ren","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"40","key":"10.1016\/j.biopha.2026.119181_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202507657","article-title":"Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas","volume":"37","author":"Isaac","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119181_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib64","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1021\/jacs.4c18308","article-title":"Lipid-siRNA Organization Modulates the Intracellular Dynamics of Lipid Nanoparticles","volume":"147","author":"Mo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib65","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119181_bib66","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug Chem."},{"issue":"709","key":"10.1016\/j.biopha.2026.119181_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci. Transl. Med"},{"issue":"35","key":"10.1016\/j.biopha.2026.119181_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400194121","article-title":"Supramolecular assembly of polycation\/mRNA nanoparticles and in vivo monocyte programming","volume":"121","author":"Hu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib69","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.biomac.3c01102","article-title":"IonizablE Polymeric Micelles with Phenylalanine Moieties Enhance Intracellular Delivery of Self-replicating RNA for long-lasting protein expression in vivo","volume":"25","author":"Mixich","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2026.119181_bib70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2021.08.061","article-title":"Self-assembled polymeric micelle as a novel mRNA delivery carrier","volume":"338","author":"Ren","year":"2021","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.biopha.2026.119181_bib71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/pharmaceutics14061205","article-title":"Polymeric Micelles with pH-responsive cross-linked core enhance in vivo mRNA delivery","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2026.119181_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040438","article-title":"Polymeric Nanoparticles Enable mRNA Transfection and Its Translation in Intervertebral Disc and Human Joint Cells, Except for M1 Macrophages","volume":"16","author":"Muenzebrock","year":"2024","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2026.119181_bib74","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s11095-022-03398-5","article-title":"Formulation of lipid-free polymeric mesoscale nanoparticles encapsulating mRNA","volume":"39","author":"Skelton","year":"2022","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/s12248-023-00844-z","article-title":"Gastrointestinal Delivery of an mRNA vaccine using immunostimulatory polymeric nanoparticles","volume":"25","author":"Kim","year":"2023","journal-title":"Aaps J."},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib76","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1021\/acs.molpharmaceut.2c00738","article-title":"Poly(aspartic acid)-based polymeric nanoparticle for local and systemic mRNA delivery","volume":"19","author":"Park","year":"2022","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.biopha.2026.119181_bib77","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.3390\/ijms26199771","article-title":"Protein Corona as a result of interaction of protein molecules with inorganic nanoparticles","volume":"26","author":"Sarimov","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib78","first-page":"9","article-title":"In vivo Protein Corona formation: characterizations, effects on engineered nanoparticles\u2019 biobehaviors, and applications","author":"Bai","year":"2021","journal-title":"Front. Bioeng. Biotechnol. Vol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib79","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-020-16772-x","article-title":"Blood circulation of soft nanomaterials is governed by dynamic remodeling of protein opsonins at nano-biointerface","volume":"11","author":"Abbina","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102803","article-title":"Spleen-targeted mRNA delivery via long-chain PEGylated lipids at low molar ratio enhances antitumor immunity against melanoma","volume":"37","author":"Liu","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib81","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119181_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294929","article-title":"Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design","volume":"14","author":"Clemente","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib84","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. & Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081976","article-title":"The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity","volume":"14","author":"Saito","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119181_bib87","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fimmu.2019.01529","article-title":"Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses","volume":"10","author":"Tesfaye","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib88","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12951-023-02210-9","article-title":"A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response","volume":"21","author":"Song","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib89","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41598-018-38080-7","article-title":"Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site","volume":"9","author":"Lys\u00e9n","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10030407","article-title":"Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19","volume":"10","author":"Qi","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031880","article-title":"The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119181_bib92","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.4049\/jimmunol.1601881","article-title":"Targeting influenza virus hemagglutinin to Xcr1(+) dendritic cells in the absence of receptor-mediated endocytosis enhances protective antibody responses","volume":"198","author":"Gudjonsson","year":"2017","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119181_bib93","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.7150\/thno.56406","article-title":"Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk\/IL-21 axis","volume":"11","author":"Gou","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biopha.2026.119181_bib94","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.7150\/ijbs.57038","article-title":"Antigen Delivery to DEC205(+) Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites","volume":"17","author":"Silva","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119181_bib95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/imm.12467","article-title":"DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?","volume":"145","author":"Niezold","year":"2015","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib96","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.vaccine.2011.01.030","article-title":"Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice","volume":"29","author":"Stylianou","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2026.119181_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.omto.2020.10.007","article-title":"Oncolytic rhabdovirus vaccine boosts chimeric anti-DEC205 priming for effective cancer immunotherapy","volume":"19","author":"Tzelepis","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"13","key":"10.1016\/j.biopha.2026.119181_bib98","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1182\/blood-2010-02-268425","article-title":"Targeting of DEC-205 on human dendritic cells results in efficient MHC class II\u2013restricted antigen presentation","volume":"116","author":"Birkholz","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3858\/emm.2009.41.2.008","article-title":"Improving vaccines by targeting antigens to dendritic cells","volume":"41","author":"Shortman","year":"2009","journal-title":"Exp. & Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J. Intern Med"},{"key":"10.1016\/j.biopha.2026.119181_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2017.05.002","article-title":"Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study","volume":"187","author":"Rostami","year":"2017","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2026.119181_bib102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.vaccine.2010.11.010","article-title":"PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration","volume":"29","author":"Stano","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-018-0386-6","article-title":"CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells","volume":"16","author":"Matsuo","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119181_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045102","article-title":"Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses","volume":"7","author":"Ejaz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119181_bib105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2023.11.008","article-title":"Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects","volume":"364","author":"Tang","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119181_bib106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Pan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119181_bib107","article-title":"Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines","volume":"34","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020222","article-title":"Plasmacytoid Dendritic Cells and Cancer Immunotherapy","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119181_bib109","first-page":"5231","article-title":"Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen","volume":"9","author":"Saluja","year":"2014","journal-title":"Int J. Nanomed."},{"issue":"7","key":"10.1016\/j.biopha.2026.119181_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114370","article-title":"A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine","volume":"43","author":"Pelletier","year":"2024","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119181_bib111","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.4049\/jimmunol.1300787","article-title":"Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion","volume":"191","author":"Tel","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119181_bib112","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0610383104","article-title":"DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes","volume":"104","author":"Bozzacco","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2026.119181_bib113","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1182\/blood-2010-02-268425","article-title":"Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation","volume":"116","author":"Birkholz","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib114","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.4049\/jimmunol.1301661","article-title":"Induction and Activation of Human Th17 by Targeting Antigens to Dendritic Cells via Dectin-1","volume":"192","author":"Duluc","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119181_bib115","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2005-01-0318","article-title":"Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti\u2013DC-SIGN antibody","volume":"106","author":"Tacken","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119181_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-024-01208-4","article-title":"Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers","author":"Yin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.biopha.2026.119181_bib117","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/eji.202149670","article-title":"Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin","volume":"52","author":"Bellmann","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2026.119181_bib120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.intimp.2019.02.050","article-title":"M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds","volume":"70","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119181_bib121","article-title":"Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib122","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI97642","article-title":"Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance","volume":"129","author":"Muraoka","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib123","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/ijms25031370","article-title":"Mannose Ligands for Mannose Receptor Targeting","volume":"25","author":"Paurevi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836274","article-title":"R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice","volume":"13","author":"Zhuang","year":"2022","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.119181_bib125","article-title":"Advancing vaccine development: evaluation of a mannose-modified lipid nanoparticle-based candidate for African swine fever p30 mRNA vaccine eliciting robust immune response in mice","volume":"270","author":"Gong","year":"2024","journal-title":"Int J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib126","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01775-23","article-title":"Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses","volume":"15","author":"Wan","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2026.119181_bib127","article-title":"Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1\/PD-L1 blockade","volume":"27","author":"Jin","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"13","key":"10.1016\/j.biopha.2026.119181_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202318515","article-title":"Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability","volume":"63","author":"Lei","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mt.2015.215","article-title":"Genetic Immunization With <em>In Vivo<\/em> Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response","volume":"24","author":"Garu","year":"2016","journal-title":"Mol. Ther."},{"issue":"27","key":"10.1016\/j.biopha.2026.119181_bib130","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1039\/D3TB00607G","article-title":"Novel \u03b1-mannose-functionalized poly(\u03b2-amino ester) nanoparticles as mRNA vaccines with increased antigen presenting cell selectivity in the spleen","volume":"11","author":"Gonz\u00e1lez-R\u00edos","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"29","key":"10.1016\/j.biopha.2026.119181_bib131","doi-asserted-by":"crossref","first-page":"11626","DOI":"10.1039\/D3SC06575H","article-title":"Synthesis of a dendritic cell-targeted self-assembled polymeric nanoparticle for selective delivery of mRNA vaccines to elicit enhanced immune responses","volume":"15","author":"Fan","year":"2024","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102520","article-title":"Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers","volume":"36","author":"Dietmair","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119181_bib133","article-title":"Multiarm-Assisted Design of Dendron-like Degradable Ionizable Lipids Facilitates Systemic mRNA Delivery to the Spleen","author":"Xue","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"44","key":"10.1016\/j.biopha.2026.119181_bib134","doi-asserted-by":"crossref","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","article-title":"Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo","volume":"18","author":"Luo","year":"2024","journal-title":"ACS Nano"},{"issue":"16","key":"10.1016\/j.biopha.2026.119181_bib135","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1021\/acsami.3c00494","article-title":"Spleen-Targeted mRNA Delivery by Amphiphilic Carbon Dots for Tumor Immunotherapy","volume":"15","author":"Chen","year":"2023","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib136","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12951-025-03681-8","article-title":"Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model","volume":"23","author":"Wu","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"10","key":"10.1016\/j.biopha.2026.119181_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202500878","article-title":"Ultrasound-Enhanced Spleen-Targeted mRNA Delivery via Fluorinated PEGylated Lipid Nanoparticles for Immunotherapy","volume":"64","author":"Chen","year":"2025","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.biopha.2026.119181_bib138","article-title":"Fluorinated Ionizable Lipids for Efficient Spleen-Targeted mRNA Delivery in Cancer Immunotherapy","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.biopha.2026.119181_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412543","article-title":"A Spleen-Targeted Tolerogenic mRNA-LNPs Vaccine for the Treatment of Experimental Asthma","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"issue":"34","key":"10.1016\/j.biopha.2026.119181_bib140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2026.119181_bib141","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216259","article-title":"Viral escape from endosomes and host detection at a glance","volume":"131","author":"Staring","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29245997","article-title":"Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids","author":"Allen","year":"2024","journal-title":"Molecules"},{"issue":"37","key":"10.1016\/j.biopha.2026.119181_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201910566","article-title":"Nanocarrier-Mediated Cytosolic Delivery of Biopharmaceuticals","volume":"30","author":"He","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib144","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acsnano.8b05151","article-title":"Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA","volume":"13","author":"Wojnilowicz","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119181_bib145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jconrel.2022.12.008","article-title":"Engineering poly- and micelleplexes for nucleic acid delivery \u2013 A reflection on their endosomal escape","volume":"353","author":"Winkeljann","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119181_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102506","article-title":"Strategies and mechanisms for endosomal escape of therapeutic nucleic acids","volume":"81","author":"Grau","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119181_bib147","doi-asserted-by":"crossref","first-page":"344","DOI":"10.20517\/evcna.2024.19","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design","volume":"5","author":"Hagedorn","year":"2024","journal-title":"Extra Vesicles Circ. Nucl. Acids"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib148","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1021\/acsami.4c20077","article-title":"Transfection Potency of Lipid Nanoparticles Containing mRNA Depends on Relative Loading Levels","volume":"17","author":"Liao","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119181_bib149","article-title":"Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis","volume":"7","author":"Kurul","year":"2025","journal-title":"Nanotechnology"},{"issue":"27","key":"10.1016\/j.biopha.2026.119181_bib150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301067120","article-title":"Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm","volume":"120","author":"Zheng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib151","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1038\/s41467-021-23997-x","article-title":"Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay","volume":"12","author":"Teo","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib152","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1038\/s41467-019-10855-0","article-title":"A split fluorescent reporter with rapid and reversible complementation","volume":"10","author":"Tebo","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib153","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acschembio.0c00804","article-title":"NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay","volume":"16","author":"Peier","year":"2021","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib154","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119181_bib155","article-title":"Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects","author":"Omo-Lamai","year":"2024","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib156","article-title":"Poly(N-methyl-N-vinylacetamide): a strong alternative to peg for lipid-based nanocarriers delivering siRNA, Adv Healthc","volume":"13","author":"Berger","year":"2024","journal-title":"Mater"},{"issue":"43","key":"10.1016\/j.biopha.2026.119181_bib157","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx5970","article-title":"Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"issue":"20","key":"10.1016\/j.biopha.2026.119181_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400327","article-title":"Localization of Intramuscular mRNA Delivery Using Deep Eutectic-Lipid Nanocomposites","volume":"13","author":"Curreri","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib159","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1021\/acsnano.2c10936","article-title":"Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles","volume":"17","author":"Mo","year":"2023","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.biopha.2026.119181_bib160","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303857","article-title":"Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA","volume":"13","author":"Jung","year":"2024","journal-title":"Adv. Health Mater."},{"issue":"6","key":"10.1016\/j.biopha.2026.119181_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403374","article-title":"Dual-Mechanism mRNA Delivery via Fluorinated-Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID-19 Vaccination","volume":"14","author":"Vasukutty","year":"2025","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2026.119181_bib162","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2021.08.029","article-title":"Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines","volume":"338","author":"Blakney","year":"2021","journal-title":"J. Control Release"},{"issue":"26","key":"10.1016\/j.biopha.2026.119181_bib163","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib164","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","article-title":"Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery","volume":"20","author":"Xue","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/vaccines13010025","article-title":"Development of a Cationic Polymeric Micellar Structure with Endosomal Escape Capability Enables Enhanced Intramuscular Transfection of mRNA-LNPs","volume":"13","author":"Deng","year":"2025","journal-title":"Vaccines"},{"issue":"13","key":"10.1016\/j.biopha.2026.119181_bib166","doi-asserted-by":"crossref","first-page":"15981","DOI":"10.1021\/acsami.4c00992","article-title":"Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery","volume":"16","author":"Yadava","year":"2024","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"9","key":"10.1016\/j.biopha.2026.119181_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092034","article-title":"Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA","volume":"9","author":"Siewert","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122675","article-title":"Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media","volume":"14","author":"Kliesch","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119181_bib169","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jconrel.2022.11.042","article-title":"Hybrid core-shell particles for mRNA systemic delivery","volume":"353","author":"Andretto","year":"2023","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2026.119181_bib170","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1039\/D4BM01405G","article-title":"Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells","volume":"13","author":"Pareja Tello","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114755","article-title":"Lipid-Polyhydroxyalkanoate Hybrid Nanoparticles as Sustainable Platform for mRNA delivery","volume":"213","author":"Mazrad","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"47","key":"10.1016\/j.biopha.2026.119181_bib172","doi-asserted-by":"crossref","first-page":"32689","DOI":"10.1021\/jacs.4c12166","article-title":"Manganese Oxide-Incorporated Hybrid Lipid Nanoparticles Amplify the Potency of mRNA Vaccine via Oxygen Generation and STING Activation","volume":"146","author":"Gan","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.biopha.2026.119181_bib173","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41591-021-01574-5","article-title":"A multiclade env\u2013gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques","volume":"27","author":"Zhang","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib174","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/vaccines13010084","article-title":"Immunogenicity of HIV-1 Env mRNA and Env-Gag VLP mRNA Vaccines in Mice","volume":"13","author":"Ma","year":"2025","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.biopha.2026.119181_bib175","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. & Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib176","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.apsb.2023.08.034","article-title":"Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"30","key":"10.1016\/j.biopha.2026.119181_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5672","article-title":"Increased PIP3 activity blocks nanoparticle mRNA delivery","volume":"6","author":"Paunovska","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119181_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114213","article-title":"Archaeal ether lipids improve internalization and transfection with mRNA lipid nanoparticles","volume":"197","author":"Sedlmayr","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119181_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125240","article-title":"Intracellular trafficking of lipid nanoparticles is hindered by cholesterol","volume":"671","author":"Luo","year":"2025","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2026.119181_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2024.11.073","article-title":"Corosolic acid derivative-based lipid nanoparticles for efficient RNA delivery","volume":"378","author":"Liu","year":"2025","journal-title":"J. Control Release"},{"issue":"37","key":"10.1016\/j.biopha.2026.119181_bib181","doi-asserted-by":"crossref","first-page":"15206","DOI":"10.1039\/D3NR02175K","article-title":"Efficient mRNA delivery using lipid nanoparticles modified with fusogenic coiled-coil peptides","volume":"15","author":"Zeng","year":"2023","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401918","article-title":"Enhancing Cytoplasmic Expression of Exogenous mRNA Through Dynamic Mechanical Stimulation","volume":"14","author":"Chen","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2026.119181_bib183","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ymthe.2024.02.028","article-title":"SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants","volume":"32","author":"Mahalingam","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119181_bib184","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.5c19036","article-title":"Comprehensive Engineering of Ionizable Lipid Nanoparticles and mRNA Elements for Next-Generation Vaccines","author":"Kim","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119181_bib185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2024.10.035","article-title":"Recent advances in mRNA-based cancer vaccines encoding immunostimulants and their delivery strategies","volume":"376","author":"Eslami","year":"2024","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.biopha.2026.119181_bib186","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-18-2867","article-title":"Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity","volume":"79","author":"Haabeth","year":"2019","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib187","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-15-0163","article-title":"Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells","volume":"4","author":"Van Lint","year":"2016","journal-title":"Cancer Immunol. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib188","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000329","article-title":"TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma","volume":"8","author":"De Keersmaecker","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"21","key":"10.1016\/j.biopha.2026.119181_bib189","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood.V116.21.2190.2190","article-title":"Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)","volume":"116","author":"Khoury","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2026.119181_bib190","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241454","article-title":"Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control","volume":"222","author":"Peng","year":"2025","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib191","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1349-7006.2007.00698.x","article-title":"Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA","volume":"99","author":"Naka","year":"2008","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119181_bib193","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2024.10.028","article-title":"Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo","volume":"376","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"issue":"42","key":"10.1016\/j.biopha.2026.119181_bib194","doi-asserted-by":"crossref","first-page":"29045","DOI":"10.1021\/acsnano.4c10154","article-title":"Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery","volume":"18","author":"Isaac","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2026.119181_bib195","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-024-55137-6","article-title":"Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering","volume":"16","author":"Padilla","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119181_bib196","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119181_bib197","article-title":"PEG-Free Monosialoganglioside Lipid Nanoparticles with Spleen-Selective mRNA Delivery for Cancer Immunotherapy","author":"Wang","year":"2025","journal-title":"Adv. Funct. Mater. N.\/a(N.\/a"},{"issue":"50","key":"10.1016\/j.biopha.2026.119181_bib198","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:30:21Z","timestamp":1779244221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":198,"alternative-id":["S0753332226002143"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119181","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted cytosolic delivery of mRNA immunotherapeutics: From vaccine delivery to protein replacement","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119181"}}